The Effect of Probiotics on the Prevention of Necrotizing Enterocolitis (NEC) in Low Birth Weight (LBW) and Very Low Birth Weight (VLBW) Infants

Document Type : Review Article

Authors

1 1. Neonatal Health Research Center, Research Institute for Children's Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran 2. Neonatal Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

2 Neonatal Health Research Center, Research Institute for Children's Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran

10.22038/ijn.2025.88290.2707

Abstract

Background: Necrotizing enterocolitis (NEC) is a life-threatening disease for premature and very low birth weight infants (VLBW).Traditional therapeutic methods such as administration of antibiotics and antacids and cessation of breastfeeding can exacerbate changes in the intestinal microbiota. The mechanisms of action are believed to involve modulation of the gut microbiome, enhancement of the gut barrier function, and immunomodulation. To review the current evidence regarding the use of probiotics for the prevention of NEC in low birth weight (LBW) and VLBW infants.
Methods: A literature search was conducted across major databases (MEDLINE, Embase, Cochrane Library), supplemented by hand-searching of relevant articles and review of reference lists. The search encompassed randomized controlled trials (RCTs), meta-analyses, and review articles published up to 2024. This review included studies that investigated the effect of probiotic supplementation on NEC incidence and related outcomes in LBW and VLBW infants. Excluded studies were those of poor methodological quality or that did not report relevant outcomes.
Results: In this study, a large number of studies on the effect of probiotics on the prevention of NEC in premature and low birth weight infants were found, which showed beneficial effects of probiotics. And probiotics have reduced the Incidence of NEC, Severity of NEC, Mortality. However, these studies were quite heterogeneous in terms of methodology and type of probiotic used. Adverse events associated with probiotic use were generally infrequent and mild, primarily involving transient diarrhea or vomiting. No significant increase in serious adverse events was reported in any of the included studies.
Conclusion: Probiotic supplementation appears to be a beneficial intervention for preventing NEC in LBW and VLBW infants  but yet The decision to use probiotics should be individualized, considering the infant’s risk factors, probiotic availability, and parental preferences.
 

Keywords

References

  1. Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med. 2011;364(3):255-64. 
  2. Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg. 1978;187(1):1-7.
  3. Uauy RD, Fanaroff AA, Korones SB, Phillips EA, Phillips JB, Wright LL, National Institute of Child Health and Human Development Neonatal Research Network. Necrotizing enterocolitis in very low birth weight infants: biodemographic and clinical correlates. J Pediatr. 1991;119(4):630-638.
  4. Hackam DJ, Sodhi CP, Good M. New insights into necrotizing enterocolitis: from laboratory observation to personalized prevention and treatment. J Pediatr Surg. 2019;54(3):398-404.
  5. Qasemi A, Lagzian M, Rahimi F, Majd FK, Bayat Z. The power of probiotics to combat urinary tract infections: A comprehensive review. Res Biotechnol Environ Sci. 2023;2(1):1-1.
  6. Bayani G, Mafinezhad S, Ehteshammanesh H, Sharifian E, Esmati M, Akbarian Sanavi M, et al. Effect of Probiotics on enteral milk tolerance and prevention of necrotizing enterocolitis in preterm neonates. Iran J Neonatol. 202112(2).
  7. Claud EC. Neonatal necrotizing enterocolitis -inflammation and intestinal immaturity. Antiinflamm Antiallergy Agents Med Chem. 2009;8(3):248-259.
  8. Qasemi A, Bayat Z, Akbari N, Babazadeh D. Bacterial resistance of acinetobacter baumannii: A global concern. Res Biotechnol Environ Sci. 2022;1(2): 36-42.
  9. Saeidi R, Javadi F. Effect of probiotics on feeding tolerance in vlbw neonates in nicu. Clin Pediatr. 2017; 2:4 (Suppl).
  10. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506-514.
  11. Saeidi R, Izanloo A. P449 Probiotics and retinopathy of premature: systemic review. Arch Dis Child. 2019;104(Suppl 3):A332.
  12. Beghetti I, Panizza D, Lenzi J, Gori D, Martini S, Corvaglia L, et al. Probiotics for preventing necrotizing enterocolitis in preterm infants: A network meta-analysis. nutrients. 2021;13(1):192.
  13. Rose EC, Odle J, Blikslager AT, Ziegler AL. Probiotics, prebiotics and epithelial tight junctions: A promising approach to modulate intestinal barrier function. Int J Mol Sci. 2021;22(13):6729.
  14. Isolauri E, Sütas Y, Kankaanpää P, Arvilommi H, Salminen S. Probiotics: effects on immunity. Am J Clin Nutr. 2001;73(2 Suppl):444S-450S.
  15. Berrington JE, Fleming PF. Probiotics for the prevention of necrotising enterocolitis in preterm infants. Early Hum Dev. 2019;135:50.
  16. Sharif S, Meader N, Oddie SJ, Rojas-Reyes MX, McGuire W. Probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants. Cochrane Database Syst Rev. 2023;7(7):CD005496.
  17. Aceti A, Gori D, Barone G, Callegari ML, Di Mauro A, Fantini MP, et al; Italian Society of Neonatology. Probiotics for prevention of necrotizing enterocolitis in preterm infants: systematic review and meta-analysis. Ital J Pediatr. 2015;41:89. 
  18. Ullah S, Khan I, Lnu A, Ullah Khan J, Syed A, Shafiq F, Khan M, Khan FR. Probiotics vs. Placebo: Preventing necrotizing enterocolitis in a premature infant. Cureus. 2024;16(9):e68848.
  19. Kruth SS, Willers C, Persad E, Sjöström ES, Lagerström SR, Rakow A. Probiotic supplementation and risk of necrotizing enterocolitis and mortality among extremely preterm infants-the Probiotics in Extreme Prematurity in Scandinavia (PEPS) trial: study protocol for a multicenter, double-blinded, placebo-controlled, and registry-based randomized controlled trial. Trials. 2024;25(1):259.
  20. Bin-Nun A, Bromiker R, Wilschanski M, Kaplan M, Rudensky B, Caplan M, et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr. 2005;147(2):192-196.
  21. Dani C, Coviello CC, Corsini II, Arena F, Antonelli A, Rossolini GM. Lactobacillus sepsis and probiotic therapy in newborns: Two new cases and literature review. AJP Rep. 2016;6(1):e25-29. 
  22. Lin HC, Su BH, Chen AC, Lin TW, Tsai CH, Yeh TF, et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics. 2005;115(1):1-4. 
  23. Deshmukh M, Patole S. Prophylactic probiotic supplementation for preterm neonates-a systematic review and meta-analysis of nonrandomized studies. Adv Nutr. 2021;12(4):1411-1423. 
  24. Athalye-Jape G, Rao S, Patole S. Effects of probiotics on experimental necrotizing enterocolitis: A systematic review and meta-analysis. Pediatr Res. 2018;83(1-1):16-22. 
  25. Jacobs SE, Tobin JM, Opie GF, Donath S, Tabrizi SN, Pirotta M, et al; ProPrems Study Group. Probiotic effects on late-onset sepsis in very preterm infants: A randomized controlled trial. Pediatrics. 2013;132(6):1055-1062. 
  26. Poindexter B, Committee on Fetus and Newborn, Cummings J, Hand I, Adams-Chapman I, Aucott SW, Puopolo KM, et al. Use of probiotics in preterm infants. Pediatrics. 2021;147(6):e2021051485.
  27. Su GL, Ko CW, Bercik P, Falck-Ytter Y, Sultan S, Weizman AV, et al. AGA clinical practice guidelines on the role of probiotics in the management of gastrointestinal disorders. Gastroenterology. 2020;159(2):697-705. 

 

 

Iranian Journal of Neonatology
Volume 16, Issue 3
July 2025
Pages 63-67

Files

Share

How to cite

Statistics